Table 1.
Analysis of Proteus Digital Health and Otsuka Pharmaceutical patent strategies for the digital pill Abilify MyCite.
| US Patent No. | Patent Expiration | The Title of the Invention, the Owners |
|---|---|---|
| 7053092 | 28/01/2022 | 5HT1a Receptor subtype agonist [10] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 7978064 | 14/09/2026 | Communication system with partial power source [11] Proteus Biomedical, Inc. (Redwood City, CA, USA) |
| 8017615 | 16/06/2024 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof [12] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 8114021 | 21/06/2030 | Body-associated receiver and method [13] Proteus Biomedical, Inc. (Redwood City, CA, USA) |
| 8258962 | 25/11/2030 | Multi-mode communication ingestible event markers and systems, and methods of using the same [14] Proteus Biomedical, Inc. (Redwood City, CA, USA) |
| 8545402 | 27/04/2030 | Highly reliable ingestible event markers and methods for using the same [15] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8547248 | 18/12/2030 | Implantable zero-wire communications system [16] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8580796 | 25/09/2022 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof [17] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 8642760 | 25/09/2022 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof [18] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 8674825 | 09/04/2029 | Pharma-informatics system [19] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8718193 | 05/12/2029 | Active signal processing personal health signal receivers [20] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8759350 | 02/03/2027 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders [21] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 8847766 | 29/03/2030 | Pharma-informatics system [22] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8945005 | 19/08/2029 | Controlled activation ingestible identifier [23] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8956288 | 06/07/2029 | In-body power source having high surface area electrode [24] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 8961412 | 17/11/2030 | In-body device with virtual dipole signal amplification [25] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9060708 | 05/03/2029 | Multi-mode communication ingestible event markers and systems, and methods of using the same [26] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9089567 | 28/01/2022 | Method of treating cognitive impairments and schizophrenias [27] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 9119554 | 16/12/2028 | Pharma-informatics system [28] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9125939 | 28/07/2026 | Carbostyril derivatives and mood stabilizers for treating mood disorders [29] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 9149577 | 15/12/2029 | Body-associated receiver and method [30] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9258035 | 05/03/2029 | Multi-mode communication ingestible event markers and systems, and methods of using the same [31] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9268909 | 15/10/2033 | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device [32] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9320455 | 15/12//2031 | Highly reliable ingestible event markers and methods for using the same [33] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9359302 | 25/09/2022 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof [34] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 9387182 | 25/12/2023 | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders [35] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |
| 9433371 | 15/09/2029 | In-body device with virtual dipole signal amplification [36] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9444503 | 19/11/2027 | Active signal processing personal health signal receivers [37] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 9941931 | 04/11/2030 | System for supply chain management [38] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 10441194 | 26/07/2029 | Ingestible event marker systems [39] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 10517507 | 13/06/2032 | Communication system with enhanced partial power source and method of manufacturing same [40] Proteus Digital Health, Inc. (Redwood City, CA, USA) |
| 11229378 | 11/07/2031 | Communication system with enhanced partial power source and method of manufacturing same [41] Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan) |